Related Experiment Video
Updated: Nov 30, 2025
Exosomal miRNA Analysis in Non-small Cell Lung Cancer NSCLC Patients' Plasma Through qPCR: A Feasible Liquid Biopsy Tool
Published on: May 27, 2016
The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy
Hiromi Konishi1, Masami Hayashi1, Kohei Taniguchi2,3
1Department of Obstetrics and Gynecology, Osaka Medical College , Takatsuki, Japan.
Abstract:
Cervical cancer is the fourth-most prevalent malignancy in women. For advanced cervical cancer, radiotherapy is a major treatment. Micro RNAs (miRNAs) are small, noncoding RNAs that negatively regulate the target gene expression posttranscriptionally. miR-22 is frequently downregulated in various cancers including cervical cancer, and is associated with a poor prognosis in cervical cancer. Exosomes are small endosomally secreted vesicles that carry components such as proteins, messenger RNA (mRNA), DNA and miRNA. We investigated whether or not exosomes can efficiently deliver miR-22 to recipient cervical cancer cells and affect the gene expression in the cells, as well as assessed the role of exosomal miR-22 in radiosensitivity. Exosomes containing high levels of miR-22 were extracted by ultracentrifugation and then characterized by Western blotting, a nanoparticle tracking analysis and electron microscopy. The high presence of miR-22 in the exosome was confirmed by real-time polymerase chain reaction. After the administration of the collected exosomal miR-22 to SKG-II and C4-I cervical cancer cells, the level of miR-22 in the cells was significantly increased, indicating the absorption of the exosomal miR-22. When miR-22 encapsulated in exosomes was administered to the SKG-II cells, the level of c-Myc binding protein (MYCBP) and human telomerase reverse transcriptase (hTERT) was significantly decreased in correlation with increased radiosensitivity determined by a clonogenic assay. Taken together, these results suggest that the administration of exosomal miR-22 may be a novel drug delivery system for cervical cancer radiotherapy.
Insights
Exosomes efficiently deliver micro RNA-22 (miR-22) to cervical cancer cells, enhancing radiosensitivity. This suggests exosomal miR-22 as a novel delivery system for cervical cancer radiotherapy.
Area of Science:
- Oncology
- Molecular Biology
- Nanotechnology
Background:
- Cervical cancer is a leading malignancy in women, with radiotherapy being a primary treatment for advanced stages.
- Micro RNAs (miRNAs), specifically miR-22, are often downregulated in cervical cancer, correlating with poor prognosis.
- Exosomes, nanoscale vesicles, can transport biomolecules including miRNAs between cells.
Purpose of the Study:
- To investigate the efficacy of exosomes in delivering miR-22 to cervical cancer cells.
- To assess the impact of exosomal miR-22 on gene expression within recipient cells.
- To determine the role of exosomal miR-22 in enhancing radiosensitivity of cervical cancer.
Main Methods:
- Exosomes with high miR-22 levels were isolated using ultracentrifugation and characterized via Western blotting, nanoparticle tracking analysis, and electron microscopy.
- miR-22 levels in exosomes and recipient cells were quantified using real-time polymerase chain reaction.
- Radiosensitivity was evaluated using a clonogenic assay after exosome administration.
Main Results:
- Exosomal miR-22 was successfully delivered to and absorbed by SKG-II and C4-I cervical cancer cells, significantly increasing intracellular miR-22 levels.
- Administration of exosomal miR-22 led to a significant decrease in c-Myc binding protein (MYCBP) and human telomerase reverse transcriptase (hTERT) expression.
- Increased radiosensitivity was observed in cervical cancer cells treated with exosomal miR-22.
Conclusions:
- Exosomes serve as an effective delivery vehicle for miR-22 into cervical cancer cells.
- Exosomal miR-22 delivery modulates key gene expression (MYCBP, hTERT) and enhances cellular radiosensitivity.
- Exosomal miR-22 represents a promising novel drug delivery system for improving cervical cancer radiotherapy outcomes.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:22MicroRNAs
01:22MicroRNAs